French Observational Xagrid (FOX) Study In Adult Patients With Essential Thrombocythemia
Condition(s):Essential ThrombocythemiaLast Updated:June 14, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Essential ThrombocythemiaLast Updated:June 14, 2021Completed
Condition(s):High Risk Polycythemia Vera; High Risk Essential ThrombocythemiaLast Updated:April 30, 2019Completed
Condition(s):Essential Thrombocythemia; Primary Myelofibrosis, Fibrotic Stage; Primary Myelofibrosis, Prefibrotic StageLast Updated:September 29, 2020Unknown status
Condition(s):Polycythemia Vera; Thrombocythemia, EssentialLast Updated:November 10, 2020Completed
Condition(s):Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-Essential Thrombocytosis MyelofibrosisLast Updated:March 25, 2024Not yet recruiting
Condition(s):Thrombocythemia, HemorrhagicLast Updated:June 2, 2021Completed
Condition(s):Essential ThrombocythaemiaLast Updated:May 26, 2016Completed
Condition(s):Essential Thrombocythemia (ET)Last Updated:June 9, 2021Completed
Condition(s):Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase; Primary Myelofibrosis; Secondary MyelofibrosisLast Updated:June 6, 2023Completed
Condition(s):Thrombocythemia; Myeloproliferative DisorderLast Updated:January 18, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.